DIN 02381710 — ALOXI 0.25 MG
ALOXI is a solution of Palonosetron marketed by KNIGHT THERAPEUTICS INC.. The full Palonosetron monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02381710
- Brand name
- ALOXI
- Active ingredient
- Palonosetron
- Strength
- 0.25 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- KNIGHT THERAPEUTICS INC.
- Health Canada status
- MARKETED
- Drug class
- Serotonin (5-HT3) receptor antagonist (antiemetic)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Palonosetron products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02381729 | ALOXI | 0.5 MG | CAPSULE | KNIGHT THERAPEUTICS INC. | DORMANT |